Having topped analysts' estimates last quarter by 3 cents per share, Bristol-Myers Squibb (NYSE:BMY) is expected to deliver its latest earnings on Wednesday, July 25, 2012.
Continue Reading Below
Analysts currently expect Bristol-Myers Squibb to come in with earnings of 50 cents per share on revenues of $4.46 billion. Estimates from analysts range from earnings per share to earnings per share. Over the past week, the average estimate has moved down from 51 cents.
In terms of price changes, the stock's best recent streak was when it gained $2.15 per share between May 8, 2012 and June 22, 2012.
Company Fundamental Trends The impending earnings announcement offers the opportunity expand on positive earnings momentum gained over last three quarters. Net income rose 2.1% in the third quarter of the last fiscal year and 76.4% in the fourth quarter of the last fiscal year before increasing again in the first quarter. On the top line, the company is looking to build on four-straight revenue increases heading into this earnings announcement. Revenue rose 14% in the second quarter of the last fiscal year, 11.4% in the third quarter of the last fiscal year and 6.7% in the fourth quarter of the last fiscal year before increasing again in the first quarter.
Analysts are split on Bristol-Myers Squibb, but nine of 20 analysts rate it hold. Analyst sentiment has been improving recently, as the average rating risen slightly over the past three months.
Last Quarter's Results
In the first quarter, profit rose 11.7% to $1.1 billion (64 cents a share) from $986 million (57 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 4.8% to $5.25 billion from $5.01 billion.
Reporting Period: 2Q
Date of Release: Wednesday, July 25, 2012 before market open
EPS: 50 cents
Revenue Estimate: $4.46 billion
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)